Immuno-Oncology Innovation Award

Submit your abstract to apply for our travel award

 

Miltenyi Biotec is excited to honor researchers around the globe for their contributions to the immuno-oncology field. Innovative research will be awarded with travel, accommodation, and registration to selected immuno-oncology meetings. In addition, the winner will have the opportunity to share his or her research with the scientific community.

Check out the list of upcoming meetings that are covered by our Immuno-Oncology Innovation Award below and submit your abstract within the given timeline to apply for the award.

Upcoming meetings covered by our Immuno-Oncology Innovation Award*:


American Association for Cancer Research (AACR) Annual Meeting
March 30–April 03, 2019 | Atlanta, Georgia, USA

Abstract submission deadline: February 14, 2019
Travel award winner announcement: March 01, 2019

The 18th Meeting of the Society for Natural Immunity
September 30–October 03, 2019 | Luxembourg

Abstract submission deadline: August 16, 2019
Travel award winner announcement: September 01, 2019


*This contest is open for participation, at no charge, according to the respective deadlines.
Simply fill out the form at the end of this page to submit your abstract.
 

Check out what the winners of our previous travel awards have to say: 

„It was a great honor for me to have my work so highly appreciated by Miltenyi Biotec. Attending the ASH 2018 in San Diego was an amazing experience, which allowed me to interact with top scientists from all over the world, to discuss my work and to initiate new partnerships.”
Mgr. Michal ŠMÍDA | Winner of the IOIA 2018 – American Society of Hematology (ASH) Annual Meeting 
Central European Institute of Technology (CEITEC) Masaryk University in Brno, Czech Republic
Michal Smida, Ph.D., is a junior research group leader at the CEITEC. His research focuses on personalized medicine for B cell malignancies, in particular developing alternative strategies to combine with immunotherapy regimens and predicting novel therapy targets based on synthetic lethality with patient mutations. His team is mainly using CRISPR/Cas9-based gene editing and cell screening with both whole-genome CRISPR knockout as well as drug libraries.
“The Chicago AACR meeting was an outstanding experience for me. I found the opportunity to interact with leaders in the field and to witness firsthand the excitement in cancer immunology to be extremely motivating. I am honored to have my work recognized by Miltenyi and would like to thank you for your dedication to innovation in immuno-oncology.”
Brian Koss | Winner of the IOIA 2018 – American Association for Cancer Research (AACR) 
University of Arkansas for Medical Sciences, Biochemistry and Molecular Biology, United States 
Brian Koss is a Ph.D. student in the Tackett lab. He specializes in the use of mass spectrometry for analysis of 
histone post-translational modifications. His current work focuses on defining epigenetic mechanisms 
driving metabolic exhaustion of tumor-infiltrating lymphocytes. 
“The San Antonio NK meeting was a really great event to hear about the latest advances in science and a great opportunity to present my work. This award is also a good way to show Miltenyi’s interest in students’ projects. This travel grant allowed me to meet a lot of amazing scientists and to discuss my project and plans with them. I’m very grateful to Miltenyi for this opportunity.”
Aurelien Colamartino | Winner of the IOIA – The 17th Meeting of the Society for Natural Immunity 
University of Montreal, CRCHU Sainte-Justine, Montreal 
Aurélien Colamartino is a Ph.D. student in the Haddad lab. His work focuses on a new, highly efficient transduction method to customize NK cells for immunotherapy, using different pseudotyped lentiviral particles.
"I was very honored to receive the Immunology-Oncology Innovation Award, which gave me the opportunity to attend an excellent conference and to present my data. Miltenyi's commitment to support innovation and young scientists is a valuable strategy to move the onco-immunology field forward."
Damya Laoui | Winner of the IOIA 2018 – 15th International Symposium on Dendritic Cells
Flanders Institute for Biotechnology, Vrije Universiteit Brussels 
Damya Laoui, Ph.D., is a research scientist in the lab of Jo Van Ginderacter. After her post-doc in the De Palma 
lab at the ISREC Institute in the Ecole Polytechnique de Lausanne, she came back to Brussels where she leads 
her own team focusing on tumor-immunology. She is exploring the role of the immune system in tumor 
progression and is developing new personalized immunotherapies based on dendritic cells. For her work in 
tumor-immunology she received several prizes.
"My group has been using the MACSQuant® Flow Cytometer for our cancer peptide binding assays to identify the activation status of NK cells."
Constantine Bitsaktsis| Winner of the AAI Travel Award 2017
Seton Hall University, South Orange
Constantine Bitsaktsis, Ph.D., is an Assistant Professor in the Department of Biological Sciences at Seton Hall University. He obtained his doctorate degree from King’s College University of London in 2002. He then moved state-side where he held two postdoctoral positions at the Wadsworth Center and the Albany Medical College in Albany, NY. His research is currently focusing on the utilization of novel vaccine approaches to combat microbial pathogens by generating long-term, protective immune responses.
"MACS® Microbeads for magnetic cell separation helped us to get 96.4% purity of a specific subset of cardiac fibroblasts out from the whole dissociated mouse heart cells."
Guobao Chen | Winner of the AAI Travel Award 2017
John Hopkins University School of Medicine, Baltimore
Guobao Chen, Ph.D., is a Research Postdoctoral Fellow (Immunology Program), in the Department of 
Pathology at Johns Hopkins University School of Medicine. Dr. Chen received his doctoral degree in 
Immunology from National University of Singapore. His current project is focusing on the mechanism 
behind post-injury cardiac inflammation and remodeling.
"The Immunology Travel Award is a great opportunity for young scientists to participate in exciting scientific conferences. It shows Miltenyi Biotec's commitment to interaction within the field of immunology and is an excellent strategy to support early career immunologists.“
Quirin Hammer | Winner of the Immunology Travel Award 2016
DRFZ, Berlin
Quirin Hammer is currently a Ph.D. student in the Romagnani lab at the German Rheumatism-Research Center, Berlin. His general research interest lies in the field of regulation of innate lymphoid cell functions. His current research project focuses on natural killer (NK) cell memory during human cytomegalovirus (HCMV) infection.
"The DC meeting 2016 was for me a unique opportunity in my Ph.D. to discuss with peers about my project but also about their project to have a larger view of the DC world. Thanks to Miltenyi Biotec's travel grant, I had a really amazing scientific time in Shanghai."
Mélanie Durand | Winner of the Immunology Travel Award 2016
Institut Curie Research Center, Paris
Mélanie Durand is currently a Ph.D. student in the Amigorena lab at the Institut Curie Research Center in Paris, 
France. Her research interest lies in the field of antigen presentation in dendritic cells and the molecular 
analysis of immune responses, particularly in the context of cancer. 

Apply now – simply fill out the form below
We will process your personal data according to our privacy statement.

Immuno-oncology supported by Miltenyi Biotec

From basic research to innovative therapies

Click here to find our various immuno-oncology activities: Benefit from our experience, meet the experts, or share your research story.
Immuno-oncology